Aspire BioPharma, Inc. (ASBP) — Cash Flow Quality Index
Aspire BioPharma, Inc. (ASBP) has a Cash Flow Quality Index of -0.10x as of June 2023. Operating cash flow of $-189.95K is below net income of $1.81 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Aspire BioPharma, Inc. (ASBP) cash conversion ratio to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Aspire BioPharma, Inc. Cash Flow Quality Index (2022–2023)
Historical Cash Flow Quality Index for Aspire BioPharma, Inc. across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Aspire BioPharma, Inc. total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Aspire BioPharma, Inc. (2022–2023)
Year-by-year earnings quality comparison for Aspire BioPharma, Inc.. For live market cap and the full company financial profile, see ASBP company net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -0.15x | $-653.11K | $4.46 Million | ▲ +65.3% |
| 2022 | -0.42x | $-1.41 Million | $3.34 Million | — |